Systemic iron-handling machinery

The systemic iron-handling machinery is a coordinated biological system responsible for maintaining iron homeostasis, ensuring sufficient iron for erythropoiesis and cellular metabolism while preventing toxic accumulation. The central regulatory component is the hepcidin-ferroportin axis, where the liver-derived hormone hepcidin controls the degradation of ferroportin, the only known cellular iron exporter. This machinery integrates signals from iron stores, erythropoietic demand, and inflammatory stimuli to regulate iron absorption in the duodenum and iron release from macrophages and hepatocytes. Other key components include transferrin for transport, transferrin receptors for uptake, and ferritin for storage. Dysregulation of this system leads to significant clinical disorders, such as hereditary hemochromatosis (iron overload) and anemia of chronic disease (iron restriction). Therapeutic strategies targeting this machinery include hepcidin mimetics, ferroportin inhibitors, and hepcidin antagonists. These drugs aim to restore physiological iron balance in patients with iron-related pathologies by modulating the availability of iron in the plasma. Understanding the molecular interactions within this machinery is essential for developing targeted treatments for complex iron-related conditions.

Other names

Iron homeostasis machineryHepcidin-ferroportin axisSystemic iron regulation systemIron metabolism pathway

Modulation of the hepcidin-ferroportin axis to regulate systemic iron levels by either mimicking hepcidin activity, inhibiting ferroportin directly, or neutralizing hepcidin to increase iron availability.